Cancer Vaccine Current Events | Cancer Vaccine News | 5
|
| Page
5 of
112 |
2229 Results |
|
|
|
Sort By:
Page Views | Date |
Who should receive vaccines and antiviral drugs in the event of a flu pandemic?
Since flu vaccine and antiviral drugs are in scarce supply, the WHO recommends that all nations determine in advance which groups of people will be the first to receive these treatments in the event of a flu pandemic. view more (2006-10-17)
Vaccinate infants of hepatitis B mothers, say experts
Immunising newborn infants of mothers with hepatitis B prevents infection being transmitted from mother to child, finds a study published online by the BMJ today. view more (2006-01-27)
Mesothelin engineered on virus-like particles provides treatment clues for pancreatic cancer
New understanding of a protein that spurs the growth of pancreatic cancer could lead to a new vaccine against the deadly disease, said researchers at Baylor College of Medicine in Houston in a report appearing in the current edition of the journal Molecular Cancer Therapeutics. view more (2008-02-15)
Edible vaccine for Hepatitis B
Edible Vaccines may play a big part in the future for protection against Hepatitis B infection. Professor Yasmin Thanavala, from Roswell Park Cancer Institute, USA, describes her research at the British Society for Immunology's Congress 2000 in Harrogate today (Wednesday 6 December 2000). The hepatitis B virus has infected more than 2 billion... view more... (2000-12-01)
Despite vaccine, public should not get complacent about pneumococcal disease
Although the childhood pneumococcal conjugate vaccine has been a boon in reducing the incidence invasive pneumococcal disease (IPD), the public and the medical community must not get complacent, as non-vaccine strains, some resistant to antibiotics, are on the rise, say scientists at a meeting today in Boston. view more (2008-06-03)
TB vaccine developed at McMaster University in Canada
McMaster University researchers are about to launch Canada's first tuberculosis (TB) vaccine clinical trial with a vaccine totally designed, manufactured and tested within McMaster. view more (2009-03-20)
Animal model shows early promise for SARS vaccine (p 1895)
Embargoed 0001 h (London time) 5 December 2003. US authors of a research letter in this week's issue of THE LANCET highlight preliminary findings which could mark an important step in the development of a human vaccine for severe acute respiratory syndrome (SARS). A genetically engineered vaccine was found to be effective in triggering an immune... view more... (2003-12-03)
Meningitis: effectiveness of preventive vaccination demonstrated
Meningitis epidemics caused by the pathogen Nesseiria meningitis (or meningococcus) provoke high mortality in children and young people under 20 years of age in sub-Saharan Africa. view more (2007-06-06)
Common Virus May Help Doctors Treat Deadly Brain Tumors
A common human virus may prove useful in attacking the deadliest form of brain tumors, according to study conducted by researchers at Duke's Preston Robert Tisch Brain Tumor Center. view more (2007-10-23)
RNA molecules, delivery system improve vaccine responses, effectiveness
A novel delivery system that could lead to more efficient and more disease-specific vaccines against infectious diseases has been developed by biomedical engineers at The University of Texas at Austin. view more (2008-10-09)
New rabies vaccine may require only a single shot... not 6
A person, usually a child, dies of rabies every 20 minutes. However, only one inoculation may be all it takes for rabies vaccination, according to new research published in the Journal of Infectious Diseases by researchers at the Jefferson Vaccine Center. view more (2009-09-21)
Smokers invite to test vaccine against nicotine addiction
UCSF's Habit Abatement Clinic is testing a vaccine that enlists help from the immune system to keep nicotine away from the brain. The vaccine is designed to help smokers quit and to limit the urge to start smoking again. view more (2006-06-12)
NIAID describes challenges, prospects for an HIV vaccine
Events of the past year in HIV vaccine research have led some to question whether an effective HIV vaccine will ever be developed. In the August 28 edition of the New England Journal of Medicine, officials from the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, examine the extraordinarily... view more... (2008-08-28)
College students who feel 'invincible' unlikely to accept vaccines, MU researcher finds
Vaccines to protect against sexually transmitted diseases, including HIV and herpes, are being developed and may soon be available to college students. view more (2009-07-30)
PROMISING RESULTS FOR MALARIA VACCINE (p 1927)
Results of a study from The Gambia in this week's issue of THE LANCET provide evidence of a vaccine that could prevent malaria caused by the micro-organism Plasmodium falciparum. P. falciparum malaria remains a major cause of disease and death in many parts of the tropics, especially in sub-Saharan Africa. The development of an effective vaccine... view more... (2001-12-05)
Novel approach for rapid identification and development of malaria vaccines
Malaria is the world's most frequent parasitic disease, affecting more than 100 countries in the tropical zones, mostly in Africa, and 40% of the world population, with more than a million deaths per year. view more (2007-07-25)
New MUHC study adds more evidence to clear measles mumps rubella vaccine as a risk factor for autism
A new MUHC study provides conclusive evidence that the Measles Mumps Rubella (MMR) vaccine is not associated with the development of autism spectrum disorders (ASDs). view more (2006-10-18)
UNC, Harvard develop inhaled TB vaccine
A new tuberculosis vaccine successfully tested at the University of North Carolina at Chapel Hill is easier to administer and store and just as effective as one commonly used worldwide. view more (2008-03-17)
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine to Conduct Innovative Smallpox Vaccine Research Study
University Hospitals Case Medical Center (UHCMC) and Case Western Reserve University School of Medicine are part of a nationwide research study to determine the safety and effectiveness of a new smallpox vaccine geared toward adults ages 18 to 34 who have never been vaccinated against the disease. view more (2007-06-04)
Chronic HIV-1 infection frequently fails to protect against superinfection
Natural HIV-1 infection does not always elicit a protective immune response, according to a new study published November 16 in PLoS Pathogens. view more (2007-11-16)
|
|
| Page
5 of
112 |
2229 Results |
|
|
|
Sort By:
Page Views | Date |
|
